A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas
Clinical trial NCT01163071 · TERMINATED
Trial details
- NCT number
- NCT01163071
- Sponsor
- Celgene
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-09-23
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.